학술논문

Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis.
Document Type
Article
Source
Rheumatology. Feb2023, Vol. 62 Issue 2, p835-840. 6p.
Subject
*ATHEROSCLEROSIS risk factors
*BIOMARKERS
*CAROTID artery
*RESEARCH
*CARDIOVASCULAR diseases risk factors
*CAROTID intima-media thickness
*ADRENOCORTICAL hormones
*ANTINEUTROPHIL cytoplasmic antibodies
*ATHEROSCLEROSIS
*RISK assessment
*CHURG-Strauss syndrome
*DISEASE duration
*DISEASE prevalence
*STATISTICAL correlation
*VASCULITIS
*DISEASE complications
*SYMPTOMS
Language
ISSN
1462-0324
Abstract
Objectives Patients affected by eosinophilic granulomatosis with polyangiitis (EGPA) display an increased risk of atherothrombotic events compared with the general population. An increased frequency of subclinical markers of atherosclerosis has been observed in other ANCA-associated vasculitis, but no specific study focused on EGPA. We therefore evaluated subclinical atherosclerosis in EGPA patients and in a control population. Methods Forty EGPA patients and 80 controls matched by age, sex and traditional cardiovascular risk factors underwent sonographic assessment of common carotid artery (CCA) intima–media thickness (IMT). The presence of plaques of the CCA was also investigated. The correlation between CCA-IMT and clinical and laboratory features was also assessed. Results Median CCA-IMT was significantly higher in EGPA patients compared with controls (P  = 0.002). Also, the proportion of subjects with increased CCA-IMT and with presence of plaques was significantly higher among EGPA patients (P  < 0.001 for both). Moreover, within the EGPA cohort, CCA-IMT tended to increase with disease duration (P  = 0.034) and corticosteroid cumulative dose (P  = 0.004). No significant associations were found between CCA-IMT, ANCA status, other clinical features and therapeutic regimens. Notably, the prevalence of traditional cardiovascular risk factors was comparable in patients with vs without an increased CCA-IMT. Conclusion Ultrasound markers of subclinical atherosclerosis are increased in EGPA patients as compared with controls, independently of traditional cardiovascular risk factors. [ABSTRACT FROM AUTHOR]